The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia-Reference-Cited by-同舟云学术

The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia

Published:2011-08-28 Issue:3 Volume:2 Page:163-174
ISSN:2190-5991
Container-title:Journal of Cachexia, Sarcopenia and Muscle
language:en
Short-container-title:J Cachexia Sarcopenia Muscle

Author:

Dallmann R.¹²,Weyermann P.¹,Anklin C.¹,Boroff M.¹,Bray-French K.¹,Cardel B.¹,Courdier-Fruh I.¹,Deppe H.¹,Dubach-Powell J.¹,Erb M.¹,Haefeli R. H.¹,Henneböhle M.¹,Herzner H.¹,Hufschmid M.¹,Marks D. L.³,Nordhoff S.¹,Papp M.⁴,Rummey C.¹,Santos G.¹,Schärer F.¹,Siendt H.¹,Soeberdt M.¹,Sumanovski L. T.¹,Terinek M.¹,Mondadori C.¹,Güven N.¹,Feurer A.¹

Affiliation:

1. Santhera Pharmaceuticals (Switzerland) Ltd.; Hammerstr. 49 4410 Liestal

2. Institute of Pharmacology and Toxicology; University of Zurich; Winterthurerstr. 190 8057 Zurich

3. Department of Pediatric Endocrinology, Vollum Institute; Oregon Health Sciences University; Portland

4. Institute of Pharmacology; Polish Academy of Sciences; Krakow

Publisher

Wiley

Subject

Physiology (medical),Orthopedics and Sports Medicine

Reference60 articles.

1. Cachexia: a new definition;Evans;Clin Nutr,2008

2. The use of melanocortin antagonists in cachexia of chronic disease;Scarlett;Expert Opin Investig Drugs,2005

3. Cachexia in cancer patients;Tisdale;Nat Rev Cancer,2002

4. Analysis of the energy balance in lung cancer patients;Staal-van Brekel;Cancer Res,1994

5. Therapy insight: cancer anorexia-cachexia syndrome-when all you can eat is yourself;Laviano;Nat Clin Pract Oncol,2005

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of TCMCB07, a melanocortin‐4 antagonist peptide, in dogs with naturally occurring cachexia;Journal of Veterinary Internal Medicine;2023-10-28

2. Systemic Reprogramming of Endothelial Cell Signaling in Metastasis and Cachexia;Physiology;2023-07-01

3. Interstitial brachytherapy for hepatocellular carcinoma: Analysis of prognostic factors for overall survival and progression free survival and application of a risk stratification model.;Digestive Diseases;2023-06-29

4. Immunoregulation in cancer-associated cachexia;Journal of Advanced Research;2023-05

5. The differential effects of sarcopenia and cachexia on overall survival for pancreatic ductal adenocarcinoma patients following pancreatectomy: A retrospective study based on a large population;Cancer Medicine;2023-03-20